Ryan Specialty Holdings, Inc. (RYAN)
| Market Cap | 9.22B -49.9% |
| Revenue (ttm) | 3.10B +19.6% |
| Net Income | 108.69M +115.3% |
| EPS | 0.77 +187.1% |
| Shares Out | 263.66M |
| PE Ratio | 45.14 |
| Forward PE | 16.54 |
| Dividend | $0.52 (1.49%) |
| Ex-Dividend Date | May 12, 2026 |
| Volume | 2,631,859 |
| Open | 35.44 |
| Previous Close | 35.28 |
| Day's Range | 34.39 - 35.44 |
| 52-Week Range | 29.28 - 69.49 |
| Beta | 0.64 |
| Analysts | Buy |
| Price Target | 42.47 (+21.45%) |
| Earnings Date | Jul 30, 2026 |
About RYAN
Ryan Specialty Holdings, Inc. operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, rest of Europe, India, Singapore, and internationally. The company offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter or a program administrator with delegated authority from insurance carriers. It serves commercial, industrial, institutional, indivi... [Read more]
Financial Performance
In 2025, Ryan Specialty Holdings's revenue was $2.99 billion, an increase of 21.95% compared to the previous year's $2.46 billion. Earnings were $63.40 million, a decrease of -33.03%.
Financial StatementsAnalyst Summary
According to 19 analysts, the average rating for RYAN stock is "Buy." The 12-month stock price target is $42.47, which is an increase of 21.45% from the latest price.
News
Ryan Specialty price target raised to $52 from $51 at UBS
UBS analyst Brian Meredith raised the firm’s price target on Ryan Specialty (RYAN) to $52 from $51 and keeps a Buy rating on the shares.
Ryan Specialty downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs downgraded Ryan Specialty (RYAN) to Neutral from Buy with a price target of $35, down from $42. The firm says its updated view for a prolonged period of…
AM Best Assigns Performance Assessment to Ryan Specialty (Singapore) Pte. Limited; Affirms Performance Assessment of Remaining Ryan Specialty Underwriting Managers' Affiliates
OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has assigned a Performance Assessment (assessment) of PA-1 (Exceptional) to Ryan Specialty (Singapore) Pte. Limited (Singapore). The outlook assign...
Ryan Specialty Holdings Transcript: 46th Annual William Blair Growth Stock Conference
A leading specialty insurance distributor leverages scale, talent, and innovation to drive growth, maintain resilience, and expand into new markets. Strong capital management and disciplined underwriting support a positive long-term outlook, even as market cycles evolve.
Ryan Specialty to Participate in the William Blair Growth Stock Conference
CHICAGO--(BUSINESS WIRE)--Ryan Specialty Holdings, Inc. (NYSE: RYAN) (“Ryan Specialty”), a leading international specialty insurance services firm, today announced that it will be presenting at the Wi...
Ryan Specialty price target raised to $44 from $42 at Keefe Bruyette
Keefe Bruyette raised the firm’s price target on Ryan Specialty (RYAN) to $44 from $42 and keeps an Outperform rating on the shares. Ryan Specialty announced a $300M increase to…
Ryan Specialty announces $300M increase to share repurchase program
Ryan Specialty (RYAN) Holdings announced that its Board of Directors on May 21, 2026 increased the authorization of its existing share repurchase program for shares of the Company’s Class A…
Ryan Specialty Announces $300 Million Increase to Share Repurchase Program
CHICAGO--(BUSINESS WIRE)--Ryan Specialty Holdings, Inc. (NYSE: RYAN) (“Ryan Specialty”), a leading international specialty insurance services firm, today announced that its Board of Directors on May 2...
Ryan Specialty price target lowered to $39 from $45 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Ryan Specialty (RYAN) to $39 from $45 and keeps an Overweight rating on the shares. Most property and casualty insurance companies saw…
Ryan Specialty price target lowered to $45 from $50 at Morgan Stanley
Morgan Stanley analyst Bob Huang lowered the firm’s price target on Ryan Specialty (RYAN) to $45 from $50 and keeps an Overweight rating on the shares.
Ryan Specialty Holdings, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
SAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Ryan Specialty Holdings, Inc. (NYSE: RYAN). The investigation focuses on Ry...
Ryan Specialty price target lowered to $51 from $59 at UBS
UBS analyst Brian Meredith lowered the firm’s price target on Ryan Specialty (RYAN) to $51 from $59 and keeps a Buy rating on the shares.
Ryan Specialty price target lowered to $50 from $55 at Citi
Citi analyst Matthew Heimermann lowered the firm’s price target on Ryan Specialty (RYAN) to $50 from $55 and keeps a Buy rating on the shares.
Ryan Specialty price target lowered to $42 from $49 at Goldman Sachs
Goldman Sachs analyst Robert Cox lowered the firm’s price target on Ryan Specialty (RYAN) to $42 from $49 and keeps a Buy rating on the shares. Investors are expected to…
Ryan Specialty price target lowered to $35 from $42 at Mizuho
Mizuho lowered the firm’s price target on Ryan Specialty (RYAN) to $35 from $42 and keeps a Neutral rating on the shares.
Ryan Specialty price target lowered to $42 from $49 at Keefe Bruyette
Keefe Bruyette lowered the firm’s price target on Ryan Specialty (RYAN) to $42 from $49 and keeps an Outperform rating on the shares.
Ryan Specialty price target lowered to $35 from $43 at Piper Sandler
Piper Sandler lowered the firm’s price target on Ryan Specialty (RYAN) to $35 from $43 and keeps a Neutral rating on the shares. The firm notes the company reported a…
Ryan Specialty price target lowered to $39 from $41 at Barclays
Barclays lowered the firm’s price target on Ryan Specialty (RYAN) to $39 from $41 and keeps an Overweight rating on the shares.
Wells downgrades Ryan Specialty to Equal Weight on below peer growth
Wells Fargo downgraded Ryan Specialty (RYAN) to Equal Weight from Overweight with a price target of $31, down from $42, following the fiscal Q2 report. The company lowered its fiscal…
Ryan Specialty downgraded to Equal Weight from Overweight at Wells Fargo
Wells Fargo analyst Elyse Greenspan downgraded Ryan Specialty (RYAN) to Equal Weight from Overweight with a $31 price target
Ryan Specialty reports Q2 adjusted EPS 47c, consensus 43c
Reports Q2 revenue $795.2M, consensus $778.48M. “It was a strong start to 2026 for Ryan Specialty (RYAN) in the face of continued and increasing industry headwinds,” said Patrick Ryan, Founder…
Ryan Specialty Holdings Earnings Call Transcript: Q1 2026
Q1 2026 saw 15% revenue growth and 20% EPS growth, but full-year guidance was lowered to mid-single-digit organic growth due to property rate declines and increased competition. Margin pressure is expected, but investments in AI, talent, and M&A remain priorities.
Ryan Specialty Holdings Earnings release: Q1 2026
Ryan Specialty Holdings released its Q1 2026 earnings on April 30, 2026, summarizing the period's financial results.
Ryan Specialty Holdings Quarterly report: Q1 2026
Ryan Specialty Holdings has published its Q1 2026 quarterly earnings report on April 30, 2026.
Ryan Specialty Reports First Quarter 2026 Results
CHICAGO--(BUSINESS WIRE)--Ryan Specialty Holdings, Inc. (NYSE: RYAN) (“Ryan Specialty” or the “Company”), a leading international specialty insurance firm, today announced results for the first quarte...